Detection of Bacterial causes of diarrhea in patients with SARS-CoV-2 in Samarraa city

Article Sidebar

pdf
Published: Nov 28, 2022
DOI: https://doi.org/10.25130/tjps.v27i4.28
Keywords:
COVID-19, bacterial Co-infection, antibiotic sensitivity pattern

Main Article Content

Noor Asaad Ahmed
Bashar Sadiq Noomi
Osama N. Najris

Abstract

The current study aimed to detection of bacterial causes of diarrhea in patients with SARS-CoV-2 in Samarraa city, for this purpose, 71 stool samples collected from SARS-CoV-2 patients with diarrhea, bacterial culture techniques, biochemical tests and vitik2 were used. The results showed that out of 71 sample,  45 Gram-negative isolates (63.38%) and 26 Gram-positive isolates (36.62%). Main bacteria spp. Were Escherichia. coli, Klebsiella pneumoniae, proteus mirabilis, Pseudomonas aeruginosa, Salmonella. typhimurium, Staphylococcus aureus, Enterococcus. fecalis

Article Details

How to Cite
Noor Asaad Ahmed, Bashar Sadiq Noomi, & Osama N. Najris. (2022). Detection of Bacterial causes of diarrhea in patients with SARS-CoV-2 in Samarraa city. Tikrit Journal of Pure Science, 27(4), 17–22. https://doi.org/10.25130/tjps.v27i4.28
Issue
Vol. 27 No. 4 (2022)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.

References

[1] Lai, C. C., Wang, C. Y., and Hsueh, P. R. (2020). Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?. Journal of Microbiology, Immunology and Infection, 53(4), 505-512.

[2] Adebisi, Y. A., Alaran, A. J., Okereke, M., Oke, G. I., Amos, O. A., Olaoye, O. C.,.. and Lucero-Prisno III, D. E.(2021). COVID-19 and Antimicrobial Resistance: A Review. Infectious Diseases: Research and Treatment, 14,11786337211033870.

[3] Arashiro, T., Nakamura, S., Asami, T., Mikuni, H., Fujiwara, E., Sakamoto, S., ... and Saito, H. (2020). SARS-CoV-2 and Legionella co-infection in a person returning from a Nile cruise. Journal of travel medicine, 27(3), taaa053.

[4] Shafran, N., Shafran, I., Ben-Zvi, H., Sofer, S., Sheena, L., Krause, I.,.. and Sklan, E. H. (2021). Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Scientific reports, 11(1), 1-8.

[5] Chhibber-Goel, J., Gopinathan, S., and Sharma, A. (2021). Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?. Gut Pathogens, 13(1), 1-6.

[6] Gil, E., Martyn, E., Rokadiya, S., Jain, S., and Chin, T. L. (2021). Bacterial Coinfection in COVID-19. Clinical Infectious Diseases, 73(3), e843-e845 [7] Al-Abbas, A. K. (2018). Etiology of bacterial diarrhea in children under five years in Kerbala Province [8] Mikhael, E. M., and Al-Jumaili, A. A. (2020). Can developing countries face novel coronavirus outbreak alone? The Iraqi situation. Public Health in Practice, 1, 100004. .

[9] Franco-Duarte, R., Černáková, L., Kadam, S., S Kaushik, K., Salehi, B., Bevilacqua, A., ... and Rodrigues, C. F. (2019). Advances in chemical and biological methods to identify microorganisms—from past to present. Microorganisms, 7(5), 130.

[10] Kourmouli, A., Valenti, M., van Rijn, E., Beaumont, H. J., Kalantzi, O. I., Schmidt-Ott, A., and Biskos, G. (2018). Can disc diffusion susceptibility tests assess the antimicrobial activity of engineered nanoparticles?. Journal of Nanoparticle Research, 20(3), 1-6.

[11] Abbey, T. C., and Deak, E. (2019). What's new from the CLSI subcommittee on antimicrobial susceptibility testing M100. Clinical Microbiology Newsletter, 41(23), 203-209.

[12] Saeed, N. K., Al-Khawaja, S., Alsalman, J., Almusawi, S., Albalooshi, N. A., and Al-Biltagi, M. (2021). Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World journal of virology, 10(4), 168.

[13] Abdul-Husin, I. F., and Abdul-Razzaq, M. S. (2021). Detection of Gyrase Enzyme among Clinical Isolates of E. coli Resistance to some Quinolone Antibiotics. Journal of Chemical Health Risks, 11(4), 419-429.

[14] Sharqi, H. M., Hassan, O. M., and Obaid, A. S. (2021). Investigation of the Antibiotic-Resistant ESKAPE Pathogens in Ramadi Hospitals, Iraq. Indian Journal of Forensic Medicine & Toxicology, 15(4), 3307. [15] Gomes, C., Ruiz-Roldán, L., Mateu, J., Ochoa, T. J., and Ruiz, J. (2019). Azithromycin resistance levels and mechanisms in Escherichia coli. Scientific reports, 9(1), 1-10.

[16] Hasan, T. H., and Al-Harmoosh, R. A. (2020). Mechanisms of antibiotics resistance in bacteria. Sys Rev Pharm, 11(6), 817-823.

[17] Cong, Y., Yang, S., and Rao, X. (2020). Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. Journal of Advanced Research, 21, 169-176.

[18] Sabeeh, R. A., Mousa, M. N., and Khudaier, B. Y. (2018). PREVALENCE AND ANTIBIOTIC SENSITIVITY OF Escherichia coli AND Klebsiella pneumoniae FROM PATIENTS AND ANIMALS IN BASRAH PROVINCE. Bas. Journal Vet. Res, 17(1), 192-208.

[19] Sharqi, H. M., Hassan, O. M., and Obaid, A. S. (2021). Investigation of the Antibiotic-Resistant ESKAPE Pathogens in Ramadi Hospitals, Iraq. Indian Journal of Forensic Medicine & Toxicology, 15(4), 3307. [20] Wang, G., Zhao, G., Chao, X., Xie, L., and Wang, H. (2020). The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. International Journal of Environmental Research and Public Health, 17(17), 6278.

[21] Shrief, R., Hassan, R. H., Zaki, M. E. S., and Rizk, M. A. (2022). Molecular Study of Associated with Urinary Tract Infection in Children. The Open Microbiology Journal, 16(1).

[22] Ghasemian, A., Mobarez, A. M., Peerayeh, S. N., and Abadi, A. B. (2019). The association of surface adhesin genes and the biofilm formation among Klebsiella oxytoca clinical isolates. New microbes and new infections, 27, 36-39.

[23] Allawi, F. A., and Motaweq, Z. Y. PHENOTYPIC AND MOLECULAR CORRELATION BETWEEN BIOFILM PRODUCTION AND ANTIBIOTIC RESISTANCE OF PROTEUS MIRABILIS ISOLATED FROM DIFFERENT CLINICAL SOURCES/IRAQ. Turkish Journal of Physiotherapy and Rehabilitation, 32, 3.

[24] Jabbar, A. H., Kadhim, M. I., and Jabbar, M. H. (2019). ANTIBIOTICS RESISTANCE PROFILE OF BACTERIAL STRAINS PRODUCED OF BIOFILM ISOLATED FROM PATIENTS IN AL-DIWANIYA CITY, IRAQ. International Journal of Engineering Applied Sciences and Technology, 4(8), 295-299 [25] Dhanda, G., Sarkar, P., Samaddar, S., and Haldar, J. (2018). Battle against vancomycin-resistant bacteria: recent developments in chemical strategies. Journal of medicinal chemistry, 62(7), 3184-3205. [26] Hooper, D. C., and Jacoby, G. A. (2016). Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harbor perspectives in medicine, 6(9), a025320. [28] Roberts, M. C., and Schwarz, S. (2017). Tetracycline and chloramphenicol resistance mechanisms. In Antimicrobial drug resistance (pp. 231-243). Springer, Cham.

[28] Ganamé, O. U. É. D. R. A. O. G. O., Hama, C. I. S. S. E., and Aly, S. A. V. A. D. O. G. O. (2020). Prevalence and resistance profile of Enterobacteriaceae producing extended spectrum Beta-Lactamases isolated from the laboratory of bacteriology and parasitology in National Public Health Laboratory of Ouagadougou.

[29] Agha, Z. H. M., and Al-Delaimi, M. S. (2021). Prevalence of common bacterial etiology and antimicrobial susceptibility pattern in patients with otitis media in Duhok Province–Iraq. Zanco Journal of Pure and Applied Sciences, 33(4), 11-25. [30] Liu, J., Chen, F., Wang, X., Peng, H., Zhang, H., and Wang, K. J. (2020). The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph12− 38 With Antibiotics Azithromycin and Rifampicin Enhances Bactericidal Activity Against Pseudomonas Aeruginosa. Frontiers in Cellular and Infection Microbiology, 10

[31] Hong, J. S., Yoon, E. J., Lee, H., Jeong, S. H., and Lee, K. (2016). Clonal dissemination of Pseudomonas aeruginosa sequence type 235 isolates carrying bla IMP-6 and emergence of bla GES-24 and bla IMP-10 on novel genomic islands PAGI-15 and-16 in South Korea. Antimicrobial agents and chemotherapy, 60(12), 7216-7223.

[32] Abd Al-Mayahi, F. S., and Jaber, S. M. (2020). A preliminary study of multiple antibiotic resistance (MAR) and extensively drug-resistant (XDR) of bacterial causing typhoid fever isolated from stool specimens in Al-Diwaniya, Iraq. EurAsian Journal of BioSciences, 14(1), 2369-2378.

[33] Uddin, M., and Ahn, J. (2018). Characterization of β-lactamase-and efflux pump-mediated multiple antibiotic resistance in Salmonella Typhimurium. Food science and biotechnology, 27(3), 921-928. [34] Salih, R. M., Rafiq, S. N., and Hamad, P. A. (2017). Vancomycin Resistance among Methicillin Resistant Staphylococcus aureus isolated from Clinical Samples in Erbil City, Iraq. Kirkuk university journal for scientific studies, 12(2), 108-20

[35] Salih, R. M., Rafiq, S. N., and Hamad, P. A. (2017). Vancomycin Resistance among Methicillin Resistant Staphylococcus aureus isolated from Clinical Samples in Erbil City, Iraq. Kirkuk university journal for scientific studies, 12(2), 108-20.

[36] Karakonstantis, S., and Kalemaki, D. (2019). Antimicrobial overuse and misuse in the community in Greece and link to antimicrobial resistance using methicillin-resistant S. aureus as an example. Journal of Infection and Public Health, 12(4), 460-464.

[37] Guo, Y., Song, G., Sun, M., Wang, J., and Wang, Y. (2020). Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Frontiers in cellular and infection microbiology, 10, 107.

[38] Unni, S., Siddiqui, T. J., and Bidaisee, S. (2021). Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms. Cureus, 13(10). [39] Al-Dahmoshi, H. O., Rabeea, H. W., Aridhee, A. S. A., Al-Khafaji, N. S., Al-Allak, M. H., Lazm, A. M., and Jebur, M. S. (2019). Phenotypic Investigation of Vancomycin, Teicoplanin and Linezolid Resistance Among Enterococcus spp. Isolated from Children Diarrhea. J Pure Appl Microbiol, 13(1), 531-6 [40] Siddhardha, B., Dyavaiah, M., and Syed, A. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug.

[41] Ning, Q., Wang, D., Cheng, F., Zhong, Y., Ding, Q., and You, J. (2021). Predicting rifampicin resistance mutations in bacterial RNA polymerase subunit beta based on majority consensus. BMC bioinformatics, 22(1), 1-16.

[42] Raza, T., Ullah, S. R., Mehmood, K., and Andleeb, S. (2018). Vancomycin resistant Enterococci: A brief review. J Pak Med Assoc, 68(5), 768-772.